This activity is designed for oncologists who treat patients with breast cancer. After participating in this activity, oncologists will be better able to:

• Define new directions in adjuvant and neoadjuvant therapies for women with advanced breast cancer
  
  
• Compare and contrast the role of various endocrine therapies in inhibiting the growth of breast tumors and the mechanisms of these therapies in the treatment of breast cancers
  
  
• Recognize the benefits and risks of endocrine therapies, including aromatase inhibitors and antiestrogens when formulating treatment plans for patients with metastatic breast cancer
  
  
• Discuss nonendocrine options and issues associated with chemotherapy and biologic therapy for metastatic breast cancer
  
  
• Consider strategies to improve bone health and reduce symptoms in breast cancer patients with bone metastases

This independent CME activity is supported by an unrestricted educational grant from Novartis Pharmaceuticals Corporation.